Valuation : Nephros, Inc.

Market Cap 49.41M 42.58M 39.92M 36.44M 68.65M 4.72B 68.87M 474M 185M 2.38B 186M 181M 7.9B P/E 2026 *
29x
P/E 2027 * 17.5x
Enterprise Value 49.41M 42.58M 39.92M 36.44M 68.65M 4.72B 68.87M 474M 185M 2.38B 186M 181M 7.9B EV / Sales 2026 *
2.23x
EV / Sales 2027 * 1.93x
Free-Float
87.11%
Yield 2026 *
-
Yield 2027 * -
1 day+5.57%
1 week+11.52%
Current month+34.22%
1 month+30.00%
3 months+22.97%
6 months+16.37%
Current year-6.76%
1 week 4.04
Extreme 4.04
4.62
1 month 3.28
Extreme 3.28
4.87
Current year 2.66
Extreme 2.6629
5.46
1 year 2.66
Extreme 2.6629
6.42
3 years 1.35
Extreme 1.35
6.42
5 years 0.91
Extreme 0.9051
9.1
10 years 0
Extreme 0
11.67
Manager TitleAgeSince
Chief Executive Officer 51 05/05/2023
Director of Finance/CFO 60 01/11/2023
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 69 19/09/2007
Director/Board Member 54 10/08/2018
Director/Board Member 58 08/09/2022
Date Insider Type Main position Quantity % Market Cap.
12/08/26 Free

Director

2,418 0.0223%
23/03/26 Fiscal year

Chief Financial Officer

137,722 1.2960%
23/03/26 Fiscal year

Chief Executive Officer

240,000 2.2585%
Change 5-day change 1-year change 3-year change Capi.($)
+5.57%+11.52%+12.90%+167.65% 49.41M
-3.09%+1.31% - - 13.21B
-0.56%-1.46%+14.69%+49.88% 10.65B
-3.42%-2.59%+49.22%+436.75% 4.08B
0.00%-2.84%+17.56%+217.07% 3.79B
-3.34%+1.73%+34.07%+123.71% 1.37B
+1.63%+0.60% - - 1.11B
-0.86%-5.07%+144.10%+158.80% 951M
-0.92%+3.45%-24.01%-14.33% 868M
+0.71%-1.42%+174.16%+240.22% 866M
Average -0.43%+0.97%+52.84%+172.47% 3.7B
Weighted average by Cap. -1.74%-0.39%+32.63%+161.78%

Financials

2026 *2027 *
Net sales 22.14M 19.07M 17.88M 16.33M 30.75M 2.12B 30.85M 212M 82.78M 1.07B 83.11M 81.3M 3.54B 25.66M 22.11M 20.73M 18.92M 35.65M 2.45B 35.76M 246M 95.95M 1.24B 96.32M 94.23M 4.1B
Net income 1.76M 1.52M 1.43M 1.3M 2.45M 169M 2.46M 16.91M 6.6M 85.12M 6.62M 6.48M 282M 2.92M 2.51M 2.36M 2.15M 4.05M 279M 4.06M 27.95M 10.91M 141M 10.95M 10.71M 466M
Net Debt - -
Logo Nephros, Inc.
Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
Employees
36
Date Price Change Volume
28/08/26 $4.550 +5.57% 21,358
27/08/26 $4.310 +6.42% 12,118
26/08/26 $4.050 -4.03% 37,618
25/08/26 $4.220 -4.31% 38,450
24/08/26 $4.410 +8.09% 71,553
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
4.550USD
Average target price
6.250USD
Spread / Average Target
+37.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NEPH Stock